• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Fabrazyme litigation back in play for Sanofi's Genzyme as appeals court overturns...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Feb 20, 2024 at 06:12: PM
via It’s been 15 years since Genzyme began rationing the Fabry disease treatment Fabrazyme after a shortage caused by contamination at a manufacturing site, marking the start of many years of litigation.

article source
 

<



Similar threads

cafead
Biotech Avrobio plans head-to-head Fabrazyme trial after FDA changes path to market
Replies
0
Views
192
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Teva resolves Baltimore&#039;s opioid litigation with $80M settlement
Replies
0
Views
3
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
With multi-state agreement worth $86M, Indivior moves to resolve more opioid litigation
Replies
0
Views
25
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
J&amp;J, BMS and AstraZeneca strike back in appeals after IRA litigation losses
Replies
0
Views
32
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Gilead forks over $40M to settle thousands of claims in web of litigation over alleged delay of safer HIV meds
Replies
0
Views
37
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote